Five AIR managers from my region are reportedly applying for two Nucala manager position openings, due to the COPD expansion. The rats are jumping ship; they know something is coming.
See ya air team
- Thread starter anonymous
- Start date
-
- Tags
- None
Managers meeting in December--they know something's up. Managers thinned first, then reps end of 1st quarter.
Thinking that specialty has any interest in air team leaders and/or reps is wrong. They have already proven they can’t sell Nucala for asthma. They can’t just drop samples and wish so they would be out of their league.
It's one of many internal mistakes made when we hire from one sales force to another. We need to be sure that we're just not settling- which is done in many sales transfer roles.
I mean, there’s a lot of validity to that point. I’ve seen air reps try to sell vaccines and it’s abysmal. No samples to drop off and they’re lost. They actually have to try to sell, not just get a signature.
AIR Team has some SMOKING HOT female reps! There all clean shaven down below, if ya know what I mean
!!! Most of ours sport the Chewbacca look. :-/In all honesty, AIR Reps sell while vaccine reps are simply order takers.AIR Team has some SMOKING HOT female reps! There all clean shaven down below, if ya know what I mean
Except most systems order via a distributor dumbass!
most AIR reps who have jumped to vaccines struggle because they have never worked so hard. AIR losers!
There have been multiple posts about our chronic cough med on Workplace. All of those posts have been under the “Specialty” division. That drug won’t come to AIR. UTI med going to contract sales. My $ is on the wipeout of GSK reps and Trelegy going to Syneos
It seems that maintaining the AIR division is no longer justifiable. Contracting out UTI and Trelegy appears to be a financially responsible decision for a company facing declining value and profitability. Additionally, the management of chronic cough should be transitioned to specialty care, and it may be time to consider shutting down the AIR division altogether. As far as AIR providing any value to the VBU, absolutely not any value other than lunches to clinic staff. The VBU retail team and systems account managers got it adequately covered.
Nobody sells shit in this industry. Don’t kid yourself
Our big busted sales ladies sell a lot! Don't kid yourself
Anyone notice that the only webinars/speaker programs being scheduled in 2025 are for Arexvy? No more funding for Trelegy programs due to it being a "mature" product. As stated above, all signs point to Trelegy and UTI med being promoted by Syneos, and Arexvy solely by Vaccine team. There is no longer a need for the AIR team. Only question is will layoffs come in March or June.
These comments seem accurate. We've been predicting the demise of AIR for so long—has the time finally come? Failing to address the points mentioned above would be financially irresponsible.
You are very misinformed on your comparison. It is the vaccine rep that has to sell...and experience the success/rejection of a true sales position. Not the Ken and Barbie approach that you have with the general Pharma type reps of the AIR team; tuna sandwiches anyone?
I’ve been praying for a severance package for the last three years. I’m hopeful that it will finally happen this year. Seems silly not to just hand Trelegy over to Syneos at this point. Out of 8 reps in my territory only 3 are GSK. Why would investors continue to shell out the money when they will get the same results at a fraction of the price. It just doesn’t make sense for GSK to keep the AIR team anymore. The ride is over